Tengion bioengineered bladder trial
This article was originally published in The Gray Sheet
Executive Summary
Firm initiates enrollment Jan. 5 in a 10-patient, Phase II clinical trial of its bioengineered bladder-shaped collagen scaffold to treat bladder malfunctions that can lead to kidney failure and incontinence. Physicians take healthy cells from the patient's bladder and send them to Tengion, where they are grown and attached to the biodegradable collagen scaffold. The product is then surgically implanted into the patient's own failing bladder (1"The Gray Sheet" April 10, 2006, p. 15)...